Regenerative Medicine Today welcomes Lorenzo Soletti, PhD. Dr. Soletti is the Director of Technology Development at Neograft Technologies, Inc. Dr. Soletti discusses technologies currently used in treating cardiovascular disease as well as a new technology called Angioshield that he and his colleagues at Neograft Technologies are developing.
For more information about Neograft Technologies, Inc., please click here.
Host John Murphy.
For more information about the McGowan Institute for Regenerative Medicine, visit:
McGowan Institute Research Site
McGowan Institute Patient Site
McGowan Institute on Facebook
McGowan Institute on Twitter
/
RSS Feed